Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

N, Friis-Møller; R, Thiébaut; P, Reiss; R, Weber; AD, Monforte; Wit S, De; W, El-Sadr; E, Fontas; S, Worm; O, Kirk; A, Phillips; CA, Sabin; JD, Lundgren; MG, Law

doi:10.1097/hjr.0b013e328336a150

Public

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Shared by NobleBlocks on Oct 1, 2010 • 12:00 AM UTC

Authors:

Friis-Møller N

Thiébaut R

Reiss P

Abstract

Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aim...

Discussions